NDC 42292-024-01 - Gabapentin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 42292-024
- Requested NDC
- 42292-024-01
- Package NDCs from labels
- 42292-024-01, 42292-024-20
- Manufacturer
- Mylan Institutional Inc.
- Effective date
- 2019-12-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabapentin - Mylan Institutional Inc. | Mylan Institutional Inc. | 2019-12-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 42292-024-01 | EA - Each | 42292-024 | 20770548-0dad-46a4-a1d1-f6e9b6971b55 | 1 | 2016-09-02 |
| 42292-024-20 | EA - Each | 42292-024 | 398d182f-a77b-4fc5-9cba-7dee40f3ac4d | 1 | 2016-09-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gabapentin | GABAPENTIN | Coupler LLC | 5954a330-c225-00bd-e063-6294a90a7581 | 2026-08-18 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Trifluent Pharma, LLC | 59442de1-7cf0-35f6-e063-6294a90a57d7 | 2026-08-17 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | cb81fd89-b32b-4538-bf5c-ab02f65b3458 | 2026-08-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 691205ba-fa65-4bc9-ba20-7d361382cff9 | 2026-08-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 97e47698-97c9-4eb5-a108-5850c2aa2818 | 2026-08-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 2ac0622c-440a-49a0-974f-726e6ac72a0e | 2026-08-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Bryant Ranch Prepack | 48037fc4-1aab-4ae8-aede-7c55b494877a | 2026-08-07 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | ddb3a54f-5224-4024-8804-b2a2f01d885e | 2026-08-06 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | fce0c123-29d7-42bf-8c8d-8be1772e2d99 | 2026-08-06 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Redpharm Drug | 58474aa7-7c6a-3a94-e063-6394a90a870b | 2026-08-05 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Coupler LLC | 583ab038-7b6e-96f8-e063-6294a90adf47 | 2026-08-04 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | e877a425-2b7f-4e43-a1f9-24019cbf9685 | 2026-07-31 | Warnings, Adverse reactions | 6CW7F3G59X |
| GABAPENTIN | GABAPENTIN | TIME CAP LABORATORIES, INC | 08880902-bd44-41b6-866b-2cbad4c3f2b1 | 2026-07-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 81243958-cc5a-4ec0-a64d-71682f949d5f | 2026-07-30 | Warnings, Adverse reactions | 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | bc525ae4-9843-4038-a1b7-0d3543e2282c | 2026-07-30 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Cardinal Health 107, LLC | 41844c21-9e2a-4332-a8ff-9b71ae9032b0 | 2026-07-30 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | TAGI Pharma, Inc. | 725878fa-1e2f-4fee-a9e1-a6e102c79625 | 2026-07-28 | Warnings, Adverse reactions | 310433 310434 6CW7F3G59X |
| Gabapentin | GABAPENTIN | Ascend Laboratories, LLC | 722de2a9-38b3-4518-b262-ba0d1346d0ba | 2026-07-24 | Warnings, Adverse reactions | 6CW7F3G59X |
| Gabapentin | GABAPENTIN | REMEDYREPACK INC. | 5a78ab50-993d-4857-be10-be665e02b353 | 2026-07-23 | Warnings, Adverse reactions | ANDA200651 310433 6CW7F3G59X |
| Gabapentin | GABAPENTIN | NuCare Pharmaceuticals, Inc. | 57383d2a-d2c7-bbdc-e063-6294a90ada98 | 2026-07-22 | Warnings, Adverse reactions | 310434 6CW7F3G59X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.